FE43DF93-13CD-493E-BEF2-A77A9E7D6926 Copenhagen Consensus Center Logo
Copenhagen Consensus Center

Rethink HIV: Treatment and Initiatives to Reduce the Impact of the HIV/AIDS Epidemic Assessment, Over Garnett

Assessment Paper

Antiretroviral treatment has changed the nature of the HIV pandemic and has been a major driver of an increase in resources devoted to health care in low income countries (Walensky and Kuritzkes), but there are questions about whether treatment has been adequately expanded, and about how to maintain the gains that have been achieved (Bertozzi, Martz et al. 2009). The global pandemic of human immunodeficiency virus (HIV) and the associated acquired immune deficiency syndrome (AIDS), emerging in 1981, was initially characterized by an exceptionally high ‘fatality rate’, where almost everyone infected would die after a long and variable incubation period (Hendriks, Medley et al. 1993). Successful combination treatment, which uses three drugs to suppress the virus to levels where the immune system ceased to be damaged and where the virus could not easily evolve into a resistant genotype, dramatically changed the outcome of HIV infection, turning it into a manageable chronic disease (Palella, Delaney et al. 1998). However, this introduction of successful treatment in 1996 quickly highlighted the gross inequities in access to health care and treatments globally, with a declining mortality, seen in North America and Western Europe that was not possible in lower income settings. A remarkable advocacy campaign led to reduced costs per person per year of antiretroviral medication along with increasing resources globally  (UNAIDS 2009; UNAIDS 2010). The goal of Universal Access to anti-retrovirals was embraced by politicians at the Gleneagles summit in 2006 and again endorsed in June 2011 by the UN General Assembly (World Health Organisation 2010). Currently there are over 6 million people on effective antiretroviral treatment globally, a great tribute to the efforts of many (UNAIDS 2010). However, this is less than half of those in current ‘need’ of treatment and the growth in resources, which for nearly a decade was 28% per year, has ceased. Would more resources be a good investment to stop deaths from HIV and stop the spread of HIV? In what follows we model the spread of HIV, the impact of antiretroviral treatment and show how the trade-offs necessary in decisions about who to treat and how to treat them influences the benefits derived from treatment programs.

Mead Over, Senior Fellow at the Center for Global Development and Geoffrey Garnett, Professor of Microparasite Epidemiology at the Imperial College London authored the Assessment Paper on the topic of Treatment.

The working paper used by the Expert Panel is available for download here, the finalized paper has been published in the Rethink HIV book by Cambridge University Press.